Californians can now buy opioid reversal drugs from the state online
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 21/04/2025 (340 days ago), so information in it may no longer be current.
SACRAMENTO, Calif. (AP) — Californians can now buy opioid reversal drugs directly from the state under a program aimed at making the life-saving medication less expensive and more accessible, officials said Monday.
The state began selling its own generic version of Narcan last year for $24 per twin-pack to businesses and local governments, and will now also sell to individual consumers online. A box containing two doses of naloxone nasal spray costs between $45 and $70 from regular pharmacies and online marketplaces.
Opioid overdose deaths, which are caused by heroin, fentanyl and oxycodone, have increased dramatically in California and across the country in recent years, reaching 7,847 in the state in 2023. But California officials say they have started to see a decline in these deaths.
The move is part of a broader push by California Gov. Gavin Newsom to try to force drug companies to lower their prices by offering cheaper, competing versions of medication under the state’s CalRx label.
“Life-saving medications shouldn’t come with a life-altering price tag. CalRx is about making essential drugs like naloxone affordable and accessible for all — not the privileged few,” Newsom said in a statement.
Naloxone, which can reverse overdoses of opioids, has been available in the U.S. without a prescription since March of 2023, when the U.S. Food and Drug Administration approved Narcan, a nasal spray brand produced by the Maryland-based pharmaceutical company Emergent BioSolutions.
California is also working on a plan to make insulin more affordable for residents. The state has an agreement with the nonprofit Civica to produce CalRx-branded insulin used to treat diabetes.